Skip to content
healthcare.dev

Azelastine Hydrochloride

NDC 61314-308, azelastine hydrochloride, solution/ drops, from Sandoz Inc.

Product NDC
61314-308
Status
Listed
Labeler
Sandoz Inc
Dosage form
SOLUTION/ DROPS
Route
INTRAOCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202305
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61314-308 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZELASTINE HYDROCHLORIDE.5 mg/mL

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
61314-308-02613140308021 BOTTLE, PLASTIC in 1 CARTON (61314-308-02) / 6 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6945fb86-27fb-4bab-8908-98772c6269c5
  • NADAC price for package 61314030802

    GET /v1/drugs/nadac/61314030802

Use it

Look up 61314-308 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61314-308 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61314-308. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.